AAAAAA

   
Results: 1-12 |
Results: 12
Effects of octreotide in a patient with parathyroid carcinoma
Authors: Ybarra, J Moises, J Torregrosa, JV Madhun, ZT Schumacher, OP
Citation: J. Ybarra et al., Effects of octreotide in a patient with parathyroid carcinoma, NEFROLOGIA, 21(4), 2001, pp. 406-410
Tc-99m-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism
Authors: Torregrosa, JV Fernandez-Cruz, L Canalejo, A Vidal, S Astudillo, E Almaden, Y Pons, F Rodriguez, M
Citation: Jv. Torregrosa et al., Tc-99m-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism, WORLD J SUR, 24(11), 2000, pp. 1386-1390
Indium-111 labelled platelet scintigraphy can predict the immunological origin of fever in patients on dialysis carrying a non-functioning renal allograft
Authors: Fuster, D Lomena, F Torregrosa, JV Oppenheimer, F Piera, C Setoain, FJ Laterza, C Herranz, R Setoain, J
Citation: D. Fuster et al., Indium-111 labelled platelet scintigraphy can predict the immunological origin of fever in patients on dialysis carrying a non-functioning renal allograft, EUR J NUCL, 27(3), 2000, pp. 314-318
Vitamin D receptor gene polymorphisms and bone mineral density in patientson hemodialysis
Authors: Torregrosa, JV Ybarra, J Moreno, A Pons, F Oppenheimer, F Torres, A
Citation: Jv. Torregrosa et al., Vitamin D receptor gene polymorphisms and bone mineral density in patientson hemodialysis, NEPHRON, 84(4), 2000, pp. 381-382
Reflex sympathetic dystrophy syndrome in renal transplant patients. A mysterious and misdiagnosed entity
Authors: Torregrosa, JV Campistol, JM
Citation: Jv. Torregrosa et Jm. Campistol, Reflex sympathetic dystrophy syndrome in renal transplant patients. A mysterious and misdiagnosed entity, NEPH DIAL T, 14(6), 1999, pp. 1364-1365
beta(2)-microglobulin removal by hemodialysis with polymethylmethacrylate membranes
Authors: Campistol, JM Torregrosa, JV Ponz, E Fenollosa, B
Citation: Jm. Campistol et al., beta(2)-microglobulin removal by hemodialysis with polymethylmethacrylate membranes, CONTR NEPHR, 125, 1999, pp. 76-85
r-H-erythropoietin therapy in the early post-transplant period
Authors: Campistol, JM Soy, D Tasias, D Vilardell, J Ricart, MJ Torregrosa, JV Cofan, F Oppenheimer, F
Citation: Jm. Campistol et al., r-H-erythropoietin therapy in the early post-transplant period, NEFROLOGIA, 19, 1999, pp. 30-33
Combined liver-kidney transplantation: Our experience
Authors: Torregrosa, JV Inigo, P Navasa, M Rimola, A Grande, L Oppenheimer, F
Citation: Jv. Torregrosa et al., Combined liver-kidney transplantation: Our experience, TRANSPLAN P, 31(6), 1999, pp. 2308-2308
Postrenal transplant erythrocytosis and insertion/deletion polymorphism ofthe angiotensin converting enzyme gene
Authors: Torregrosa, JV Poch, E Oriola, J Campistol, JM Cofan, F Inigo, P Oppenheimer, F
Citation: Jv. Torregrosa et al., Postrenal transplant erythrocytosis and insertion/deletion polymorphism ofthe angiotensin converting enzyme gene, TRANSPLAN P, 31(6), 1999, pp. 2319-2320
Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis
Authors: Inigo, P Torregrosa, JV Campistol, JM Oppenheimer, F
Citation: P. Inigo et al., Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis, TRANSPLAN P, 31(6), 1999, pp. 2321-2321
Bone mineral density after renal transplantation: Long-term follow-up
Authors: Moreno, A Torregrosa, JV Pons, F Campistol, JM de Osaba, MJM Oppenheimer, F
Citation: A. Moreno et al., Bone mineral density after renal transplantation: Long-term follow-up, TRANSPLAN P, 31(6), 1999, pp. 2322-2323
Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up
Authors: Brunet, M Torregrosa, JV Oppenheimer, F Corbella, J
Citation: M. Brunet et al., Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up, TRANSPLAN P, 30(8), 1998, pp. 4068-4069
Risultati: 1-12 |